Interrogate the SARS-CoV-2 genome with NGS

Form submitted successfully. Thank you. You may access the webinars below.

SARS-CoV-2 testing and sequencing for international arrivals reveals significant cross border transmission of high-risk variants into the United Kingdom


Dr. Marco Loddo
Co-Founder and Scientific Director, Oncologica UK Ltd, UK

Pivoting from cancer to COVID-19 in a global pandemic


Prof. Dr. Paul Hofman
Head of the Laboratory of Clinical and Experimental Pathology at the University Hospital Nice, France

Implementation of SARS-CoV2 NGS analysis at Amsterdam UMC


Dr. Ir. Marcel Jonges
Laboratory Head of Medical Microbiology and Infection Prevention, Amsterdam UMC, The Netherlands

SARS-CoV-2: Insights from sequencing the complete viral genome


Timothy Triche, MD, PhD
Co-Director, Center for Personalized Medicine Program, Children's Hospital Los Angeles

SARS-CoV-2 genome sequencing from post-mortem FFPE lung tissue


Nicky D’Haene, MD PhD
Department of Pathology, Erasme Hospital, Université Libre de Bruxelles (ULB), Brussels, Belgium

Integrated approach of virus sequencing and host genetics in a COVID-19 North Portuguese cohort


Dr. Luisa Pereira
Principal Researcher & Group Leader, i3S-IPATIMUP

SARS-CoV-2 variants: Role of real-time genomic sequencing in COVID-19 response


Dr. Barbara Bartolini
Senior Scientist at Microbiology Laboratory and Infectious Diseases Biorepository at the National Institute for Infectious Diseases "L. Spallanzani" (INMI), Rome, Italy

A main event and multiple introductions of SARS-CoV-2 initiated the COVID-19 epidemic in Greece


Dr. Ioannis Karakasiliotis
Assistant Professor in Medical Biology and Molecular Virology Medical School, Democritus University of Thrace, Alexandroupolis, Greece

The role of the wastewater-based epidemiology at the time of the COVID-19 pandemic


Dr. Ing. Shelesh Agrawal
Microbiology Group Leader, Technical University of Darmstadt, Institut IWAR, Germany

Role of NGS in SARS CoV-2 Outbreak Management


Dr. Varsha Potdar
Scientist, National Institute of Virology, India


Dr. Chaitanya Joshi
Director, Gujarat Biotech Research Institute, India


Dr. Yvonne Lin
Product Manager, Clinical Sequencing Division, Thermo Fisher Scientific

Molecular Pathology Activities In The Covid-19 Era


Nicola Normanno
Istituto Nazionale per lo Studio e la Cura dei Tumori SC Biologia Cellulare e Bioterapie

Featured Ion Torrent NGS solutions for SARS-CoV-2 research

Rapid sequencing of the complete SARS-CoV-2 genome for epidemiology research

The Ion AmpliSeq SARS-CoV-2 Research Panel for the Genexus Integrated Sequencer enables complete viral genome sequencing and variant detection of SARS-CoV-2 with >99% coverage. Rapidly go from nucleic acid to variant report in under a single day with minimal hands-on time. Bring simple, practical NGS to your lab. Learn more

Request virtual demo of the Ion Torrent Genexus System

Comprehensive, end-to-end immunology solutions for vaccine research

Ion Torrent targeted NGS provides a multi-dimensional approach to repertoire sequencing and immune response, enabling a deeper understanding of the adaptive immune system and its role in human health and response to infection and vaccines. Each assay is part of an end-to-end workflow that includes simple data analysis tools so you can focus on the biological meaning of your data.

Discover our solutions for vaccine research and study additional factors that influence host genetics and immune pathways:

  • TCR and BCR sequencing
  • Microbiome analysis
  • Gene expression and transcriptome analysis